NFKB1 and Parkinson disease: We also studied the co-expression network of two brain regions, the substantia nigra and amygdala, between PD and control phenotypes, and characterized the enhanced activity of the “TNF-α signaling via the NF-κB” pathway as a significant pathway in substantia nigra-mediated αSN neurotoxicity during PD.